APT Medical Inc
SSE:688617
Net Margin
APT Medical Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
A
|
APT Medical Inc
SSE:688617
|
39.5B CNY |
33%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
197.2B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
154.8B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.8B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
104.8B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.9B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.2B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.3B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
279.5B CNY |
31%
|
APT Medical Inc
Glance View
APT Medical Inc. is a company embedded in the intricate world of medical devices, specializing in the development, production, and distribution of cardiovascular and peripheral vascular medical products. The company’s foundation rests on its ability to innovate and provide solutions that address the complex challenges faced by healthcare professionals in the treatment of heart and vascular diseases. APT Medical strategically focuses on minimally invasive technologies, which are increasingly preferred for their reduced patient recovery times and overall improvement in procedural success rates. By keeping its pulse on the evolving demands within the healthcare sector, APT Medical efficiently aligns its research and development initiatives to meet the global standards and expectations. Revenue streams for APT Medical Inc. flow primarily from its broad portfolio of interventional medical devices, such as guidewires, balloon catheters, and vascular closure devices. The intricacy of their manufacturing processes, coupled with stringent regulatory requirements, ensures that their offerings are both high in quality and competitively priced. Through a network of strategic partnerships, distribution channels, and a robust export framework, the company extends its reach across several international markets. By maintaining a keen focus on customer service and post-market support, APT Medical not only thrives on initial sales but also secures a steady stream of revenue from recurring purchases and long-term partnerships with healthcare institutions globally.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on APT Medical Inc's most recent financial statements, the company has Net Margin of 32.9%.
You don't have any saved screeners yet